E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
ARQT holding history
Arcutis Biotherapeutics, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ARQT overviewAll 13F holders of ARQTFull Q2 2026 holdings
- Shares (Q2 2026)
- 11,390
- Value
- $298.6K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 11,390 | $298.6K | <0.1% | −11,617−50.5% | Reduced | Holders |
| Q1 2026 | 23,007 | $542.0K | <0.1% | – | No prior filing | Holders |
| Q3 2025 | – | – | – | – | Not filed | Holders |
| Q2 2025 | 17,184 | $240.9K | <0.1% | +2,197+14.7% | Added | Holders |
| Q1 2025 | 14,987 | $234.4K | <0.1% | +108+0.7% | Added | Holders |
| Q4 2024 | 14,879 | $207.3K | <0.1% | −2,906−16.3% | Reduced | Holders |
| Q3 2024 | 17,785 | $165.4K | <0.1% | +2,026+12.9% | Added | Holders |
| Q2 2024 | 15,759 | $146.6K | <0.1% | −23,107−59.5% | Reduced | Holders |
| Q1 2024 | 38,866 | $385.2K | <0.1% | +38,866 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −21,535−100.0% | Sold out | Holders |
| Q3 2023 | 21,535 | $114.0K | <0.1% | −5,342−19.9% | Reduced | Holders |
| Q2 2023 | 26,877 | $256.0K | <0.1% | +9,578+55.4% | Added | Holders |
| Q1 2023 | 17,299 | $190.0K | <0.1% | +1,419+8.9% | Added | Holders |
| Q4 2022 | 15,880 | $235.0K | <0.1% | +3,933+32.9% | Added | Holders |
| Q3 2022 | 11,947 | $228.0K | <0.1% | +11,947 | New | Holders |